CVS Health Corporation (NYSE:CVS)
Market Cap | 89.73B |
---|---|
Revenue | 330.92B |
Gross Profit | 128.08B |
Shares Out | 1.28B |
EPS (ttm) | 3.02 |
PE Ratio | 22.5847 |
Forward PE | 7.9363 |
Dividend Rate (ttm) | 2.2854 |
Dividend Yield | 0.0327 |
Trading Day | Jun 2 |
---|---|
Last Price | $69.99 |
Previous Close | $68.88 |
Change ($) | 1.11 |
Change (%) | 1.61% |
Day's Open | 69.34 |
Day's Range | 68.66 - 70.34 |
Day's Volume | 7.35M |
52 Week Range | 66.34 - 105.02 |
About CVS Health Corporation
millions of times a day, close to home and across the country, we’re helping people on their path to better health. we’re reinventing pharmacy to have a more active, supportive role in each person’s unique health experience and in the greater health care environment—from advising on prescriptions to helping manage chronic and specialty conditions to providing quality walk-in medical care and pharmacy benefits management.
because we’re present in so many moments, in ways that are more affordable and effective, we’re able to positively influence health behavior and shape the future of health care for people, businesses and communities. health is everything.
through our more than 9,600 retail pharmacies, over 1,100 walk-in medical clinics, 75 million pharmacy benefit manager plan members, and expanding specialty pharmacy services, we enable people, businesses and communities to manage health in more affordable, effective ways. this unique integrated model increases access to quality care,.
News
Quick info
Woonsocket
Rhode Island
02895-6146
CVS Health Corporation income statements (2022) (USD)
August 2022 | August 2022 | May 2022 | February 2022 | |
---|---|---|---|---|
Total Revenue | 80.64B | 80.64B | 76.83B | 76.60B |
Cost of Revenue | 49.29B | 49.29B | 45.51B | 46.38B |
Gross Profit | 31.35B | 31.35B | 31.32B | 30.23B |
Research & Development | 0 | 0 | 0 | 0 |
Selling General & Admin | 0 | 0 | 0 | 0 |
Operating Expense | 76.07B | 76.07B | 73.34B | 73.02B |
Operating Income | 4.57B | 4.57B | 3.49B | 3.59B |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | 4.57B | 4.57B | 3.49B | 3.59B |
Interest Income | 583M | 583M | 586M | 608M |
Pretax Income | 4.03B | 4.03B | 2.95B | 1.57B |
Income Tax | 1.07B | 1.07B | 633M | 274M |
Minority Interest | 10M | 10M | 1M | -10M |
Net Income | 2.95B | 2.95B | 2.31B | 1.31B |
Net Income Basic | 2.95B | 2.95B | 2.31B | 1.31B |
CVS Health Corporation income statements (2021) (USD)
November 2021 | August 2021 | May 2021 | February 2021 | |
---|---|---|---|---|
Total Revenue | 73.79B | 72.62B | 69.10B | 69.55B |
Cost of Revenue | 45.01B | 43.52B | 40.89B | 42.45B |
Gross Profit | 28.78B | 29.10B | 28.20B | 27.10B |
Research & Development | 0 | 0 | 0 | 0 |
Selling General & Admin | 0 | 0 | 0 | 0 |
Operating Expense | 70.30B | 68.29B | 65.52B | 67.03B |
Operating Income | 3.49B | 4.33B | 3.58B | 2.52B |
Other Income Expense Net | 0 | 0 | 0 | 0 |
EBIT | 3.49B | 4.33B | 3.58B | 2.52B |
Interest Income | 602M | 636M | 657M | 678M |
Pretax Income | 2.15B | 3.74B | 2.97B | 1.23B |
Income Tax | 558M | 0.94B | 746M | 241M |
Minority Interest | -11M | 8M | 1M | 2M |
Net Income | 1.60B | 2.78B | 2.22B | 0.97B |
Net Income Basic | 1.60B | 2.78B | 2.22B | 0.97B |
CVS Health Corporation income statements (2020) (USD)
November 2020 | June 2020 | March 2020 | |
---|---|---|---|
Total Revenue | 67.06B | 65.29B | 66.79B |
Cost of Revenue | 40.94B | 51.99B | 54.73B |
Gross Profit | 26.12B | 13.30B | 12.06B |
Research & Development | 0 | N.A | N.A |
Selling General & Admin | 0 | N.A | N.A |
Operating Expense | 63.81B | 60.59B | 63.23B |
Operating Income | 3.25B | 4.70B | 3.56B |
Other Income Expense Net | 0 | -738M | -784M |
EBIT | 3.25B | 4.70B | 3.56B |
Interest Income | 731M | 761M | 727M |
Pretax Income | 1.81B | 3.96B | 2.78B |
Income Tax | 587M | 0.97B | 767M |
Minority Interest | -5M | 11M | 5M |
Net Income | 1.22B | 2.98B | 2.01B |
Net Income Basic | 1.22B | 2.98B | 2.01B |
CVS Health Corporation income statements (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Total Revenue | 66.87B | 64.81B | 63.43B | 61.65B |
Cost of Revenue | 55.20B | 53.29B | 52.06B | 50.71B |
Gross Profit | 11.67B | 11.52B | 11.37B | 10.94B |
Research & Development | N.A | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A | N.A |
Operating Expense | 63.74B | 61.77B | 59.99B | 58.81B |
Operating Income | 3.13B | 3.04B | 3.44B | 2.84B |
Other Income Expense Net | -798M | -0.91B | -847M | -899M |
EBIT | 3.13B | 3.04B | 3.44B | 2.84B |
Interest Income | 726M | 742M | 772M | 778M |
Pretax Income | 2.33B | 2.13B | 2.59B | 1.94B |
Income Tax | 590M | 604M | 660M | 512M |
Minority Interest | -3M | -1M | -5M | 6M |
Net Income | 1.75B | 1.53B | 1.94B | 1.42B |
Net Income Basic | 1.75B | 1.53B | 1.94B | 1.42B |
CVS Health Corporation income statements (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Total Revenue | 54.42B | 47.27B | 46.71B | 45.69B |
Cost of Revenue | 40.56B | 39.94B | 39.51B | 38.83B |
Gross Profit | 13.86B | 7.33B | 7.20B | 6.86B |
Research & Development | N.A | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A | N.A |
Operating Expense | 51.03B | 44.85B | 44.34B | 43.62B |
Operating Income | 3.39B | 2.42B | 2.37B | 2.08B |
Other Income Expense Net | -3.29B | -524M | -4.44B | -605M |
EBIT | 3.39B | 2.42B | 2.37B | 2.08B |
Interest Income | 723M | 670M | 685M | 522M |
Pretax Income | 102M | 1.90B | -2.07B | 1.47B |
Income Tax | 524M | 509M | 497M | 472M |
Minority Interest | -2M | 0 | 0 | 0 |
Net Income | -419M | 1.39B | -2.56B | 1B |
Net Income Basic | -419M | 1.39B | -2.56B | 1B |
CVS Health Corporation income statements (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Total Revenue | 48.39B | 46.18B | 45.69B |
Cost of Revenue | 40.49B | 39.05B | 38.75B |
Gross Profit | 7.90B | 7.13B | 6.94B |
Research & Development | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A |
Operating Expense | 45.18B | 43.67B | 43.42B |
Operating Income | 3.20B | 2.51B | 2.27B |
Other Income Expense Net | -392M | -449M | -405M |
EBIT | 3.20B | 2.51B | 2.27B |
Interest Income | 305M | 250M | 251M |
Pretax Income | 2.81B | 2.06B | 1.86B |
Income Tax | -478M | 777M | 766M |
Minority Interest | 0 | 0 | 0 |
Net Income | 3.28B | 1.28B | 1.10B |
Net Income Basic | 3.28B | 1.28B | 1.10B |
CVS Health Corporation balance sheet (2023) (USD)
February 2023 | |
---|---|
Current Cash | 15.72B |
Receivables | 27.28B |
Inventory | 19.09B |
Current Assets | 65.68B |
Other Current Assets | 2.69B |
Short Term Investments | 2.69B |
Long Term Investments | 162.59B |
Property/Plant Equipment | 12.87B |
Good Will | N.A |
Intangible Assets | 24.75B |
Tangible Assets (Net) | -31.89B |
Other Assets | 7.85B |
Total Assets | 228.28B |
Accounts Payable | 14.84B |
Other Current Liabilities | 53.12B |
Total Current Liabilities | 69.74B |
Total Liabilities | 157.26B |
Long Term Debt | 50.48B |
Current Long Term Debt | 1.78B |
Minority Interest | 300M |
Common Stock | 1.31B |
Treasury Stock | -31.86B |
Retained Earnings | 56.15B |
Capital Surplus | N.A |
Shareholder Equity | 71.02B |
Other Liabilities | N.A |
CVS Health Corporation balance sheet (2022) (USD)
August 2022 | August 2022 | May 2022 | February 2022 | |
---|---|---|---|---|
Current Cash | 14.99B | 14.99B | 11.34B | 12.53B |
Receivables | 27.23B | 27.23B | 26.45B | 24.43B |
Inventory | 17.38B | 17.38B | 18.16B | 17.76B |
Current Assets | 62.14B | 62.14B | 61.48B | 60.01B |
Other Current Assets | 2.54B | 2.54B | 5.53B | 5.29B |
Short Term Investments | 2.54B | 2.54B | 5.53B | 5.29B |
Long Term Investments | 168.14B | 168.14B | 171.39B | 172.99B |
Property/Plant Equipment | 12.76B | 12.76B | 12.84B | 12.90B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 28.14B | 28.14B | 28.54B | 29.03B |
Tangible Assets (Net) | -31.51B | -31.51B | -33.77B | -33.07B |
Other Assets | 8.99B | 8.99B | 9.55B | 9.80B |
Total Assets | 230.28B | 230.28B | 232.87B | 233B |
Accounts Payable | 13.24B | 13.24B | 12.74B | 12.54B |
Other Current Liabilities | 51.20B | 51.20B | 52.83B | 51.06B |
Total Current Liabilities | 68.46B | 68.46B | 69.78B | 67.81B |
Total Liabilities | 155.10B | 155.10B | 159.04B | 157.92B |
Long Term Debt | 50.80B | 50.80B | 52.06B | 51.97B |
Current Long Term Debt | 4.02B | 4.02B | 4.22B | 4.21B |
Minority Interest | 322M | 322M | 310M | 306M |
Common Stock | 1.31B | 1.31B | 1.31B | 1.32B |
Treasury Stock | -30.41B | -30.41B | -30.15B | -28.17B |
Retained Earnings | 58.71B | 58.71B | 56.49B | 54.91B |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 75.18B | 75.18B | 73.83B | 75.08B |
Other Liabilities | N.A | N.A | N.A | N.A |
CVS Health Corporation balance sheet (2021) (USD)
November 2021 | August 2021 | May 2021 | February 2021 | |
---|---|---|---|---|
Current Cash | 12.84B | 10.13B | 8.79B | 10.85B |
Receivables | 25.28B | 24.16B | 23.86B | 21.74B |
Inventory | 17.40B | 16.98B | 17.62B | 18.50B |
Current Assets | 60.84B | 56.56B | 55.72B | 56.37B |
Other Current Assets | 5.32B | 5.29B | 5.46B | 5.28B |
Short Term Investments | 5.32B | 5.29B | 5.46B | 5.28B |
Long Term Investments | 174.05B | 174.61B | 173.89B | 174.35B |
Property/Plant Equipment | 12.77B | 12.66B | 12.61B | 12.61B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 29.55B | 30.08B | 30.64B | 31.14B |
Tangible Assets (Net) | -34.36B | -36.39B | -39.34B | -41.31B |
Other Assets | 9.78B | 9.70B | 9.21B | 9.51B |
Total Assets | 234.89B | 231.16B | 229.61B | 230.72B |
Accounts Payable | 12.70B | 11.05B | 10.80B | 11.14B |
Other Current Liabilities | 50.45B | 48.20B | 46.63B | 45.44B |
Total Current Liabilities | 64.71B | 59.31B | 60.10B | 62.02B |
Total Liabilities | 160.58B | 157.92B | 158.76B | 161.33B |
Long Term Debt | 56.83B | 59.29B | 59.27B | 59.21B |
Current Long Term Debt | 1.56B | 60M | 2.67B | 5.44B |
Minority Interest | 310M | 321M | 314M | 312M |
Common Stock | 1.32B | 1.32B | 1.31B | 1.31B |
Treasury Stock | -28.17B | -28.25B | -28.1B | -28.18B |
Retained Earnings | 54.26B | 53.33B | 51.20B | 49.64B |
Capital Surplus | N.A | N.A | N.A | N.A |
Shareholder Equity | 74.31B | 73.24B | 70.85B | 69.39B |
Other Liabilities | N.A | N.A | N.A | N.A |
CVS Health Corporation balance sheet (2020) (USD)
November 2020 | June 2020 | March 2020 | |
---|---|---|---|
Current Cash | 12.09B | 14.87B | 10.08B |
Receivables | 23.82B | 19.72B | 20.20B |
Inventory | 17.48B | 16.52B | 16.98B |
Current Assets | 59.21B | 62.51B | 58.96B |
Other Current Assets | 5.83B | 6B | 6.23B |
Short Term Investments | 5.83B | 2.60B | 2.63B |
Long Term Investments | 173.69B | 18.87B | 17.10B |
Property/Plant Equipment | 12.35B | 32.79B | 32.82B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 31.70B | 32.23B | 32.73B |
Tangible Assets (Net) | -42.47B | -12.04B | -14.85B |
Other Assets | 9.36B | 9.05B | 9.05B |
Total Assets | 232.90B | 235.50B | 230.64B |
Accounts Payable | 11.68B | 32.82B | 33.26B |
Other Current Liabilities | 44.92B | 20.91B | 18.46B |
Total Current Liabilities | 62.04B | 63.69B | 59.56B |
Total Liabilities | 164.09B | 167.14B | 165.17B |
Long Term Debt | 61.55B | 82.09B | 84.47B |
Current Long Term Debt | 5.44B | 8.19B | 5.83B |
Minority Interest | 305M | 11M | 5M |
Common Stock | 46.39B | 1.31B | 1.31B |
Treasury Stock | -28.16B | 28.24B | 28.18B |
Retained Earnings | 49.33B | 48.77B | 46.46B |
Capital Surplus | N.A | N.A | N.A |
Shareholder Equity | 68.81B | 68.02B | 65.14B |
Other Liabilities | N.A | N.A | N.A |
CVS Health Corporation balance sheet (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Current Cash | 5.68B | 5.20B | 6.07B | 5.90B |
Receivables | 17.24B | 17.78B | 17.42B | 18.64B |
Inventory | 17.52B | 16.03B | 15.51B | 15.45B |
Current Assets | 50.30B | 48.19B | 46.90B | 47.86B |
Other Current Assets | 5.11B | 4.84B | 4.69B | 4.57B |
Short Term Investments | 2.37B | 2.33B | 2.46B | 2.43B |
Long Term Investments | 17.59B | 17.61B | 17.24B | 16.68B |
Property/Plant Equipment | 32.90B | 32.41B | 32.35B | 32.34B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 33.12B | 33.66B | 34.16B | 35.15B |
Tangible Assets (Net) | -137.79B | -16.93B | -18.2B | -19.39B |
Other Assets | 8.79B | 8.71B | 8.77B | 8.67B |
Total Assets | 224.29B | 220.11B | 218.90B | 219.77B |
Accounts Payable | 30.97B | 29.56B | 27.99B | 26.82B |
Other Current Liabilities | 16.95B | 16.34B | 15.26B | 15.11B |
Total Current Liabilities | 53.30B | 52.54B | 49.38B | 50.63B |
Total Liabilities | 160.12B | 157.18B | 157.31B | 159.76B |
Long Term Debt | 83.63B | 83.03B | 85.79B | 86.85B |
Current Long Term Debt | 3.78B | 3.78B | 3.89B | 3.89B |
Minority Interest | -3M | -1M | -5M | 6M |
Common Stock | 1.30B | 1.30B | 1.30B | 1.30B |
Treasury Stock | 28.24B | 28.21B | 28.26B | 28.22B |
Retained Earnings | 45.11B | 44.02B | 43.14B | 41.86B |
Capital Surplus | N.A | 45.84B | 45.70B | 45.60B |
Shareholder Equity | 63.86B | 62.61B | 61.28B | 59.69B |
Other Liabilities | N.A | N.A | N.A | N.A |
CVS Health Corporation balance sheet (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Current Cash | 4.07B | 41.60B | 43.83B | 42.04B |
Receivables | 16.81B | 14.84B | 14.16B | 13.96B |
Inventory | 16.45B | 14.82B | 14.92B | 14.82B |
Current Assets | 45.24B | 71.98B | 73.79B | 71.80B |
Other Current Assets | 4.58B | 623M | 785M | 854M |
Short Term Investments | 2.52B | 105M | 96M | 119M |
Long Term Investments | 15.96B | 229M | 228M | 227M |
Property/Plant Equipment | 11.35B | 10.42B | 10.25B | 10.14B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 36.52B | 13.17B | 13.32B | 13.39B |
Tangible Assets (Net) | -142.87B | 2.40B | 1.39B | 558M |
Other Assets | 8.70B | 1.50B | 1.48B | 1.47B |
Total Assets | 198.21B | 131.51B | 133.29B | 135.14B |
Accounts Payable | 26.44B | 21.16B | 20.31B | 18.98B |
Other Current Liabilities | 15.59B | 6.16B | 7.64B | 7.72B |
Total Current Liabilities | 44.01B | 29.46B | 31.49B | 30.25B |
Total Liabilities | 139.67B | 94.88B | 97.68B | 96.46B |
Long Term Debt | 71.44B | 60.75B | 61.57B | 61.55B |
Current Long Term Debt | 1.27B | 2.14B | 3.54B | 3.54B |
Minority Interest | -2M | 0 | 0 | 0 |
Common Stock | 1.30B | 1.02B | 1.02B | 1.02B |
Treasury Stock | 28.23B | 37.73B | 37.78B | 37.75B |
Retained Earnings | 40.91B | 41.84B | 40.97B | 44.04B |
Capital Surplus | 45.42B | 32.36B | 32.26B | 32.19B |
Shareholder Equity | 58.23B | 36.62B | 35.61B | 38.67B |
Other Liabilities | N.A | N.A | N.A | N.A |
CVS Health Corporation balance sheet (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Current Cash | 1.71B | 2.49B | 2.09B |
Receivables | 13.18B | 12.44B | 12.27B |
Inventory | 15.30B | 14.15B | 14.27B |
Current Assets | 31.23B | 29.92B | 29.40B |
Other Current Assets | 0.93B | 776M | 690M |
Short Term Investments | 111M | 75M | 75M |
Long Term Investments | 190M | N.A | N.A |
Property/Plant Equipment | 10.29B | 9.91B | 10.07B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 13.63B | 13.30B | 13.35B |
Tangible Assets (Net) | -59.14B | -3.31B | -3.99B |
Other Assets | 1.34B | 1.54B | 1.56B |
Total Assets | 95.13B | 92.85B | 92.53B |
Accounts Payable | 19.22B | 17.71B | 17.58B |
Other Current Liabilities | 6.61B | 8.40B | 8.13B |
Total Current Liabilities | 30.65B | 28.51B | 26.86B |
Total Liabilities | 57.44B | 57.99B | 58.38B |
Long Term Debt | 22.18B | 23.39B | 25.62B |
Current Long Term Debt | 3.55B | 2.29B | 42M |
Minority Interest | 0 | 0 | 0 |
Common Stock | 1.01B | 1.01B | 1.02B |
Treasury Stock | 37.80B | 37.80B | 37.45B |
Retained Earnings | 43.56B | 40.78B | 40.01B |
Capital Surplus | 32.08B | 32.01B | 31.87B |
Shareholder Equity | 37.69B | 34.86B | 34.14B |
Other Liabilities | N.A | N.A | N.A |
CVS Health Corporation cash flow (2023) (USD)
February 2023 | |
---|---|
Net Income | 2.30B |
Depreciation | 1.05B |
Changes in Receivables | 27.28B |
Changes in Inventories | 19.09B |
Cash Change | 15.72B |
Cash Flow | -1.95B |
Capital Expenditures | -688M |
Investments | N.A |
Investing Activity (other) | N.A |
Total Investing Cash Flows | -119M |
Dividends Paid | N.A |
Net Borrowings | 33.85B |
Other Financing Cash Flows | N.A |
Cash Flow Financing | -2.19B |
Exchange Rate Effect | N.A |
CVS Health Corporation cash flow (2022) (USD)
November 2022 | August 2022 | |
---|---|---|
Net Income | -3.42B | 2.95B |
Depreciation | 1.06B | 1.09B |
Changes in Receivables | 26.32B | 27.23B |
Changes in Inventories | 18.06B | 17.38B |
Cash Change | 19.99B | 14.99B |
Cash Flow | 9.12B | 5.44B |
Capital Expenditures | -580M | -408M |
Investments | N.A | N.A |
Investing Activity (other) | N.A | N.A |
Total Investing Cash Flows | -805M | -2.13B |
Dividends Paid | N.A | N.A |
Net Borrowings | 29.74B | 37.28B |
Other Financing Cash Flows | N.A | N.A |
Cash Flow Financing | -3.22B | -2.46B |
Exchange Rate Effect | N.A | N.A |
CVS Health Corporation cash flow (2021) (USD)
November 2021 | |
---|---|
Net Income | 1.60B |
Depreciation | 1.13B |
Changes in Receivables | 25.28B |
Changes in Inventories | 17.40B |
Cash Change | 12.84B |
Cash Flow | 5.52B |
Capital Expenditures | -608M |
Investments | N.A |
Investing Activity (other) | N.A |
Total Investing Cash Flows | -847M |
Dividends Paid | N.A |
Net Borrowings | 40.23B |
Other Financing Cash Flows | N.A |
Cash Flow Financing | -1.97B |
Exchange Rate Effect | N.A |
CVS Health Corporation cash flow (2020) (USD)
November 2020 | June 2020 | March 2020 | |
---|---|---|---|
Net Income | 1.22B | 2.98B | 2.01B |
Depreciation | 3.30B | 1.10B | 1.09B |
Changes in Receivables | 1.30B | 480M | -2.96B |
Changes in Inventories | 0.96B | 462M | 541M |
Cash Change | -5.38B | 4.81B | 4.38B |
Cash Flow | 12.30B | 7.12B | 3.31B |
Capital Expenditures | -1.72B | -448M | -742M |
Investments | N.A | -731M | -247M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -4.3B | -1.33B | -1.6B |
Dividends Paid | N.A | -663M | -652M |
Net Borrowings | 49.08B | -263M | 3.19B |
Other Financing Cash Flows | N.A | -64M | -20M |
Cash Flow Financing | -4.42B | -0.98B | 2.68B |
Exchange Rate Effect | N.A | N.A | N.A |
CVS Health Corporation cash flow (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Net Income | 1.75B | 1.53B | 1.94B | 1.42B |
Depreciation | 1.10B | 1.09B | 1.07B | 1.11B |
Changes in Receivables | 546M | -360M | 1.22B | -1.83B |
Changes in Inventories | -1.49B | -526M | -62M | 1B |
Cash Change | 485M | -869M | 170M | 1.87B |
Cash Flow | 2.63B | 2.93B | 5.34B | 1.95B |
Capital Expenditures | -567M | -601M | -573M | -716M |
Investments | -90M | -119M | -215M | -61M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -709M | -829M | -0.91B | -891M |
Dividends Paid | -651M | -646M | -657M | -649M |
Net Borrowings | -778M | -2.37B | -3.58B | 1.40B |
Other Financing Cash Flows | -38M | -26M | -34M | -39M |
Cash Flow Financing | -1.44B | -2.97B | -4.26B | 816M |
Exchange Rate Effect | N.A | N.A | N.A | N.A |
CVS Health Corporation cash flow (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Net Income | -419M | 1.39B | -2.56B | 1B |
Depreciation | 807M | 620M | 647M | 644M |
Changes in Receivables | -1.97B | -679M | -194M | -783M |
Changes in Inventories | -1.63B | 103M | -95M | 464M |
Cash Change | -37.53B | -2.23B | 1.79B | 40.36B |
Cash Flow | 2.48B | 1.10B | 2.93B | 2.36B |
Capital Expenditures | -585M | -540M | -430M | -482M |
Investments | 139M | -15M | 9M | -8M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -41.9B | -634M | -621M | -131M |
Dividends Paid | -510M | -510M | -510M | -508M |
Net Borrowings | 2.43B | -2.27B | N.A | 38.10B |
Other Financing Cash Flows | -57M | -2M | -33M | 442M |
Cash Flow Financing | 1.89B | -2.69B | -520M | 38.14B |
Exchange Rate Effect | -4M | N.A | N.A | N.A |
CVS Health Corporation cash flow (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Net Income | 3.28B | 1.28B | 1.10B |
Depreciation | 622M | 615M | 623M |
Changes in Receivables | -741M | -166M | -160M |
Changes in Inventories | -1.13B | 128M | 36M |
Cash Change | -789M | 391M | -123M |
Cash Flow | -136M | 2.61B | 2B |
Capital Expenditures | -506M | -524M | -431M |
Investments | -46M | 5M | 8M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -1.32B | -434M | -620M |
Dividends Paid | -510M | -511M | -512M |
Net Borrowings | 1.17B | -0.99B | -668M |
Other Financing Cash Flows | -1M | -10M | -50M |
Cash Flow Financing | 670M | -1.79B | -1.5B |
Exchange Rate Effect | 1M | N.A | N.A |
CVS Health Corporation dividends (USD)
Ex date | Payment date | Record date | Declared date | Amount | Description | Frequency |
---|---|---|---|---|---|---|
20-04-2023 | 01-05-2023 | 21-04-2023 | N.A | 0.61 | Ordinary Shares | Quarterly |
19-01-2023 | 01-02-2023 | 20-01-2023 | N.A | 0.61 | Ordinary Shares | Quarterly |
21-07-2022 | 01-08-2022 | 22-07-2022 | N.A | 0.55 | Ordinary Shares | Quarterly |
21-10-2021 | 01-11-2021 | 22-10-2021 | N.A | 0.50 | Ordinary Shares | Quarterly |
21-10-2020 | 02-11-2020 | 22-10-2020 | N.A | 0.50 | Ordinary Shares | Quarterly |
22-07-2020 | 03-08-2020 | 23-07-2020 | N.A | 0.50 | Ordinary Shares | Quarterly |
22-04-2020 | 04-05-2020 | 23-04-2020 | N.A | 0.50 | Ordinary Shares | Quarterly |
22-01-2020 | 03-02-2020 | 23-01-2020 | N.A | 0.50 | Ordinary Shares | Quarterly |
23-10-2019 | 04-11-2019 | 24-10-2019 | N.A | 0.50 | Ordinary Shares | Quarterly |
24-07-2019 | 02-08-2019 | 25-07-2019 | N.A | 0.50 | Ordinary Shares | Quarterly |
22-04-2019 | 03-05-2019 | 23-04-2019 | N.A | 0.50 | Ordinary Shares | Quarterly |
24-01-2019 | 04-02-2019 | 25-01-2019 | N.A | 0.50 | Ordinary Shares | Quarterly |
23-10-2018 | 01-11-2018 | 24-10-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
24-07-2018 | 01-08-2018 | 25-07-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
20-04-2018 | 03-05-2018 | 23-04-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
23-01-2018 | 02-02-2018 | 24-01-2018 | N.A | 0.50 | Ordinary Shares | Quarterly |
23-10-2017 | 03-11-2017 | 24-10-2017 | N.A | 0.50 | Ordinary Shares | Quarterly |
20-07-2017 | 03-08-2017 | 24-07-2017 | N.A | 0.50 | Ordinary Shares | Quarterly |
19-04-2017 | 01-05-2017 | 21-04-2017 | N.A | 0.50 | Ordinary Shares | Quarterly |
20-01-2017 | 02-02-2017 | 24-01-2017 | N.A | 0.50 | Ordinary Shares | Quarterly |
20-10-2016 | 03-11-2016 | 24-10-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
19-07-2016 | 01-08-2016 | 21-07-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
20-04-2016 | 02-05-2016 | 22-04-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
20-01-2016 | 02-02-2016 | 22-01-2016 | N.A | 0.43 | Ordinary Shares | Quarterly |
20-10-2015 | 02-11-2015 | 22-10-2015 | N.A | 0.35 | Ordinary Shares | Quarterly |
21-07-2015 | 03-08-2015 | 23-07-2015 | N.A | 0.35 | Ordinary Shares | Quarterly |
Total Valuation
CVS Health Corp has a market cap or net worth of $89.73 billion. The enterprise value is $130.24 billion.
Important Dates
Share Statistics
CVS Health Corp has 1.28 billion shares outstanding.
Valuation Ratios
The trailing PE ratio is 22.5847 and the forward PE ratio is 7.9363. CVS Health Corp's PEG ratio is -0.4544.
Stock Price Statistics
The stock price has decreased by -0.2376%. The beta is 0.5974, so CVS Health Corp's price volatility has been lower than the market average.
Income Statement
In the last 12 months, CVS Health Corp had revenue of $330.92 billion and earned $128.08 billion in profits. Earnings per share was $3.02.